Myrthala Moreno‐Smith

1.9k total citations
15 papers, 843 citations indexed

About

Myrthala Moreno‐Smith is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Myrthala Moreno‐Smith has authored 15 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Cancer Research. Recurrent topics in Myrthala Moreno‐Smith's work include Neuroblastoma Research and Treatments (6 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Myrthala Moreno‐Smith is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Myrthala Moreno‐Smith collaborates with scholars based in United States, Belgium and Italy. Myrthala Moreno‐Smith's co-authors include Anil K. Sood, Susan K. Lutgendorf, Rebecca L. Stone, Mian M.K. Shahzad, Guillermo N. Armaiz-Peña, Steve W. Cole, Nicholas B. Jennings, Chunhua Lu, Lingegowda S. Mangala and Masato Nishimura and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Scientific Reports.

In The Last Decade

Myrthala Moreno‐Smith

15 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myrthala Moreno‐Smith United States 11 311 247 229 147 125 15 843
Archana S. Nagaraja United States 14 356 1.1× 392 1.6× 280 1.2× 166 1.1× 137 1.1× 22 1.1k
Michael Gallagher Ireland 16 388 1.2× 159 0.6× 232 1.0× 197 1.3× 86 0.7× 30 941
Adam M. Lee United States 13 229 0.7× 104 0.4× 238 1.0× 108 0.7× 44 0.4× 27 723
Isabel A Lüthy Argentina 22 457 1.5× 405 1.6× 302 1.3× 123 0.8× 254 2.0× 58 1.4k
Sabine Herterich Germany 20 358 1.2× 69 0.3× 104 0.5× 188 1.3× 76 0.6× 37 970
Jessica Moline United States 16 279 0.9× 260 1.1× 202 0.9× 216 1.5× 109 0.9× 28 1.1k
Breanne D.W. Karanikolas United States 6 243 0.8× 491 2.0× 197 0.9× 71 0.5× 215 1.7× 6 793
M. Frigo Italy 18 290 0.9× 88 0.4× 153 0.7× 43 0.3× 339 2.7× 41 1.1k
Yan Gan China 17 369 1.2× 58 0.2× 267 1.2× 90 0.6× 90 0.7× 49 1.3k
Yangyang Feng China 12 360 1.2× 97 0.4× 94 0.4× 107 0.7× 35 0.3× 20 731

Countries citing papers authored by Myrthala Moreno‐Smith

Since Specialization
Citations

This map shows the geographic impact of Myrthala Moreno‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myrthala Moreno‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myrthala Moreno‐Smith more than expected).

Fields of papers citing papers by Myrthala Moreno‐Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myrthala Moreno‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myrthala Moreno‐Smith. The network helps show where Myrthala Moreno‐Smith may publish in the future.

Co-authorship network of co-authors of Myrthala Moreno‐Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Myrthala Moreno‐Smith. A scholar is included among the top collaborators of Myrthala Moreno‐Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myrthala Moreno‐Smith. Myrthala Moreno‐Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Goethem, Alan Van, Nurten Yigit, Celine Everaert, et al.. (2023). Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation. NAR Cancer. 5(1). zcad002–zcad002. 3 indexed citations
2.
Tao, Ling, Mahmoud A. Mohammad, Giorgio Milazzo, et al.. (2022). MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nature Communications. 13(1). 3728–3728. 38 indexed citations
3.
Moreno‐Smith, Myrthala, Giorgio Milazzo, Ling Tao, et al.. (2021). Restoration of the molecular clock is tumor suppressive in neuroblastoma. Nature Communications. 12(1). 4006–4006. 32 indexed citations
4.
Foster, Jennifer H., Eveline Barbieri, Linna Zhang, et al.. (2021). The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma. International Journal of Molecular Sciences. 22(12). 6565–6565. 8 indexed citations
5.
Nasholm, Nicole, Amanda Balboni Iniguez, Matthew D. Hall, et al.. (2021). The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Neoplasia. 23(6). 624–633. 9 indexed citations
6.
Moreno‐Smith, Myrthala, Chunhua Lu, Mian M.K. Shahzad, et al.. (2021). Editor's Note: Dopamine Blocks Stress-mediated Ovarian Carcinoma Growth. Clinical Cancer Research. 27(15). 4451–4451. 1 indexed citations
7.
Moreno‐Smith, Myrthala, Zaowen Chen, Ling Tao, et al.. (2017). p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Clinical Cancer Research. 23(21). 6629–6639. 20 indexed citations
8.
Goethem, Alan Van, Nurten Yigit, Myrthala Moreno‐Smith, et al.. (2017). Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma. Oncotarget. 8(34). 57047–57057. 26 indexed citations
9.
Goethem, Alan Van, Nurten Yigit, Celine Everaert, et al.. (2016). Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples. Scientific Reports. 6(1). 37876–37876. 11 indexed citations
10.
Moreno‐Smith, Myrthala, Chunhua Lü, Mian M.K. Shahzad, et al.. (2011). Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth. Clinical Cancer Research. 17(11). 3649–3659. 92 indexed citations
11.
Spannuth, Whitney A., Lingegowda S. Mangala, Rebecca L. Stone, et al.. (2010). Converging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma. Molecular Cancer Therapeutics. 9(8). 2377–2388. 33 indexed citations
12.
Lu, Chunhua, Mian M.K. Shahzad, Myrthala Moreno‐Smith, et al.. (2010). Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biology & Therapy. 9(3). 176–182. 66 indexed citations
13.
Shahzad, Mian M.K., Jesusa M.G. Arevalo, Guillermo N. Armaiz-Peña, et al.. (2010). Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis. Journal of Biological Chemistry. 285(46). 35462–35470. 157 indexed citations
14.
Moreno‐Smith, Myrthala, Susan K. Lutgendorf, & Anil K. Sood. (2010). Impact of Stress on Cancer Metastasis. Future Oncology. 6(12). 1863–1881. 332 indexed citations
15.
Goepfert, Thea M., Myrthala Moreno‐Smith, David G. Edwards, et al.. (2006). Loss of chromosomal integrity drives rat mammary tumorigenesis. International Journal of Cancer. 120(5). 985–994. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026